WallStreetZenWallStreetZen

NASDAQ: SLGL
Sol Gel Technologies Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SLGL

Based on 1 analyst offering 12 month price targets for Sol Gel Technologies Ltd

Min Forecast
$50.00-28.06%
Avg Forecast
$50.00-28.06%
Max Forecast
$50.00-28.06%

Should I buy or sell SLGL stock?

Based on 1 analyst offering ratings for Sol Gel Technologies Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SLGL's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SLGL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SLGL stock forecasts and price targets.

SLGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-22

1 of 1

Forecast return on equity

Is SLGL forecast to generate an efficient return?

Company
-2.95%
Industry
94.83%
Market
354.35%
SLGL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SLGL forecast to generate an efficient return on assets?

Company
-2.22%
Industry
28.11%
SLGL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SLGL earnings per share forecast

What is SLGL's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$6.95
Avg 2 year Forecast
-$0.28

SLGL revenue forecast

What is SLGL's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$5.4M
Avg 2 year Forecast
$17.4M

SLGL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLGL$69.50$50.00-28.06%Buy
CHRS$1.60$4.00+150.00%Strong Buy
TARA$5.01$23.50+369.06%Strong Buy
CRDF$2.88$10.00+247.22%Buy
RNAC$7.42$38.67+421.12%Strong Buy
View Top Biotech Stocks

Sol Gel Technologies Stock Forecast FAQ

Is Sol Gel Technologies Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SLGL) stock is to Buy SLGL stock.

Out of 1 analyst, 0 (0%) are recommending SLGL as a Strong Buy, 1 (100%) are recommending SLGL as a Buy, 0 (0%) are recommending SLGL as a Hold, 0 (0%) are recommending SLGL as a Sell, and 0 (0%) are recommending SLGL as a Strong Sell.

If you're new to stock investing, here's how to buy Sol Gel Technologies stock.

What is SLGL's earnings growth forecast for 2026-2027?

(NASDAQ: SLGL) Sol Gel Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 210.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,200.39%.

Sol Gel Technologies's earnings in 2026 is N/A.On average, 3 Wall Street analysts forecast SLGL's earnings for 2026 to be -$19,350,634, with the lowest SLGL earnings forecast at -$18,591,785, and the highest SLGL earnings forecast at -$19,919,770.

In 2027, SLGL is forecast to generate -$767,206 in earnings, with the lowest earnings forecast at -$737,119 and the highest earnings forecast at -$789,771.

What is SLGL's revenue growth forecast for 2026-2027?

(NASDAQ: SLGL) Sol Gel Technologies's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 11,509.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,518.74%.

Sol Gel Technologies's revenue in 2026 is N/A.On average, 3 Wall Street analysts forecast SLGL's revenue for 2026 to be $15,004,249, with the lowest SLGL revenue forecast at $14,413,662, and the highest SLGL revenue forecast at $15,444,403.

In 2027, SLGL is forecast to generate $48,589,697 in revenue, with the lowest revenue forecast at $46,684,219 and the highest revenue forecast at $50,018,806.

What is SLGL's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SLGL) forecast ROA is -2.22%, which is lower than the forecast US Biotechnology industry average of 28.11%.

What is SLGL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SLGL price target, the average SLGL price target is $50.00, with the highest SLGL stock price forecast at $50.00 and the lowest SLGL stock price forecast at $50.00.

The Wall Street analyst predicted that Sol Gel Technologies's share price could fall to $50.00 by Dec 22, 2026. The average Sol Gel Technologies stock price prediction forecasts a potential downside of 28.06% from the current SLGL share price of $69.50.

What is SLGL's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SLGL) Sol Gel Technologies's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that SLGL's EPS will be -$6.95 for 2026, with the lowest EPS forecast at -$6.67, and the highest EPS forecast at -$7.15. In 2027, SLGL's EPS is forecast to hit -$0.28 (min: -$0.26, max: -$0.28).

What is SLGL's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SLGL) forecast ROE is -2.95%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.